β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development

Peptides

Volumn 30, Issue 10, 2009, Pages 1854-1860

  Kost, Natalya V ^a   Sokolov, Oleg Yu ^a   Kurasova, Oksana B ^b   Dmitriev, Alexander D ^a   Tarakanova, Julia N ^a   Gabaeva, Marina V ^a   Zolotarev, Yuriy A ^c   Dadayan, Alexander K ^c   Grachev, Sergei A ^d   Korneeva, Yekaterina V ^b   Mikheeva, Inna G ^b   Zozulya, Andrey A ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Casomorphins 7; Breast feeding; Formula feeding; Infants; Muscle tone; Psychomotor development

Indexed keywords

BETA CASOMORPHINE 7; BETA CASOMORPHINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MILK; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; INFANT; INFANT FEEDING; MAJOR CLINICAL STUDY; MUSCLE TONE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOMOTOR DEVELOPMENT; RADIOIMMUNOASSAY;

ANIMALS; BREAST FEEDING; CATTLE; DIET; ENDORPHINS; FEEDING BEHAVIOR; HUMANS; INFANT; INFANT FORMULA; MILK; MILK, HUMAN; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PSYCHOMOTOR PERFORMANCE;

BOVINAE;

EID: 70349330822     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.06.025     Document Type: Article

References (45)

1. Alcorn A., Berney T., Bretherton K., Mills M., Savery D., and Shattock P. Urinary compounds in autism. J Intellect Disabil Res 48 March Pt 3 (2004) 274-278
2. Banks W.A., and Kastin A.J. Saturable transport of peptides across the blood-brain barrier. Life Sci 41 (1987) 1319-1338
3. Brantl V., Pfeiffer A., Herz A., Henschen A., and Lottspeich F. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. Peptides 3 5 (1982) 793-797
4. Brantl V., Teschemacher H., Henschen A., and Lottspeich F. Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe Seylers Z Physiol Chem 360 9 (1979) 1211-1216
5. Brantl V., and Neubert K. Opioid peptides derived from food proteins. TJPS 7 (1986) 6-7
6. Cade R., Privette M., Fregly M., Rowland N., Sun Z., and Zele V. Autism and schizophrenia: intestinal disorders. Nutr Neurosci 3 (2000) 57-72
7. Cass H., Gringras P., March J., McKendrick I., O'Hare A.E., Owen L., et al. Absence of urinary opioid peptides in children with autism. Arch Dis Child 93 9 (2008) 745-750
8. Dettmer K., Hanna D., Whetstone P., Hansen R., and Hammock B.D. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal Bioanal Chem 388 August (8) (2007) 1643-1651
9. Dmitriev A.D., Golikova Y.I., and Kobilyanskiy A.G. Elaboration of specific antiserum to opioid peptides and their employment to radioimmune assay of that materials. Neurochem. Russ. 1 1 (1982) 66-74
10. Dubynin V.A., Ivleva I.A., Beliaeva I.A., Dobriakova I.V., Andreeva L.A., and Kamenskiǐ A.A. Influence of acute and chronic administrations of beta-casomorphins on the maternal motivation in albino rats. Ross Fiziol Zh Im I M Sechenova 91 1 (2005) 80-88
11. Dubynin V.A., Ivleva Y.A., Stovolosov I.S., Belyaeva Y.A., Dobryakova Y.V., Andreeva L.A., et al. Effect of beta-casomorphines on mother-oriented ("child's") behavior of white rats. Dokl Biol Sci 412 (2007) 1-4
12. Dubynin V.A., Malinovskaia I.V., Beliaeva I.A., Stovolosov I.S., Bespalova Z.D., Andreeva L.A., et al. Delayed effect of exorphins on learning of albino rat pups. Izv Akad Nauk Ser Biol 1 (2008) 53-60
13. Dubynin V.A., Malinovskaya I.V., Ivleva Y.A., Andreeva L.A., Kamenskii A.A., and Ashmarin I.P. Delayed behavioral effects of beta-casomorphin-7 depend on age and gender of albino rat pups. Bull Exp Biol Med 130 11 (2000) 1031-1034
14. Dubynin V.A., Zemskaia N.I., Ivleva I.A., Kamenskiǐ A.A., Andreeva L.A., and Miasoedov N.F. Behavioural effects of beta-casomorphin-7 in its intranasal administration. Zh Vyssh Nerv Deiat Im I P Pavlova 54 3 (2004) 373-381
15. Erlandsson I., Lindstrom L., and Nyberg F. B-casomorphin-8 immunoreactive material in human urine. In: Nyberg F., and Brantl V. (Eds). β-Casomorphins and related peptides (1990), Fyris-Tryck AB, Uppsala, Sweden 151-155
16. Hedner J., and Hedner T. β-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. Life Sci 41 November (20) (1987) 2303-2312
17. Jarmołowska B., Sidor K., Iwan M., Bielikowicz K., Kaczmarski M., Kostyra E., et al. Changes of beta-casomorphin content in human milk during lactation. Peptides 28 10 (2007) 1982-1986
18. Jurba L.T., and Mastukova E.M. Disturbance of psychomotor development in infants of the first year of life (1981), Medicina, Moscow
19. Kaminski S., Cieslińska A., and Kostyra E. Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet 48 3 (2007) 189-198
20. Kammerer E., Koch S., and Leon Roque D.M. Action of (d-Pro4)-beta-casomorphin1-5 on processes of synaptic transmission. Biomed Biochim Acta 44 9 (1985) 1379-1387
21. Koh G., and Brantl V. Binding of β-casomorphins to opioid receptors. In: Nyberg F., and Brantl V. (Eds). β-Casomorphins and related peptides (1990), Fyris-Tryck AB, Uppsala, Sweden 43-52
22. Leonardo E.D., and Hen R. Genetics of affective and anxiety disorders. Annu Rev Psychol 57 (2006) 117-137
23. Liebmann C., Mentz P., Schnittler M., Neubert K., and Barth A. Non-opioid effects of β-casomorphin-5 in guinea-pig heart: alterations to the β-adrenoceptors-G-protein complex and inhibition of myocardial responses to isoproterenol. Peptides 12 2 (1991) 265-270
24. Lindström L.H., Nyberg F., Terenius L., Bauer K., Besev G., Gunne L.M., et al. CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis. Am J Psychiatry 141 9 (1984) 1059-1066
25. Matthies H., Stark H., Hartrodt B., Ruethrich H.L., Spieler H.T., Barth A., et al. Derivatives of beta-casomorphins with high analgesic potency. Peptides 5 3 (1984) 463-470
26. Miller R.G., Chang K., Cooper B., and Cuatrecasas P. Radioimmunoassay and characterization of enkephalins in rat tissues. J Biol Chem 253 (1978) 531-538
27. Nedvídková J., Kasafírek E., Dlabac A., and Felt V. Effect of beta-casomorphin and its analogue on serum prolactin in the rat. Exp Clin Endocrinol 85 2 (1985) 249-252
28. Nyberg F., Lieberman H., Lindström L.H., Lyrenäs S., Koch G., and Terenius L. Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma levels. J Clin Endocrinol Metab 68 2 (1989) 283-289
29. Pasi A., Mahler H., Lansel N., Bernasconi C., and Messiha F.S. B-casomorphin-immunoreactivity in the brain stem of the human infant. Res. Commun Chem Pathol Pharmacol 80 (1993) 305-322
30. Reichelt K.L., and Knivsberg A.M. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?. Nutr Neurosci 6 1 (2003) 19-28
31. Reichelt K.L. Biochemistry and psychophysiology of autistic syndromes. Tidsskr Nor Laegeforen 114 12 (1994) 1432-1434
32. Rüthrich H.L., Grecksch G., and Schmidt R. Phe1-substituted beta-casomorphin-5 analogues with analgesic activity. Peptides 15 3 (1994) 457-460
33. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. Adv Exp Med Biol 606 (2008) 295-317
34. Sakaguchi M., Koseki M., Wakamatsu M., and Matsumura E. Effects of beta-casomorphin-5 on passive avoidance response in mice. Biosci Biotechnol Biochem 67 11 (2003) 2501-2504
35. Sakaguchi M., Koseki M., Wakamatsu M., and Matsumura E. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice. Eur J Pharmacol 530 1-2 (2006) 81-87
36. Shattock P., and Whiteley P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 6 2 (2002) 175-183
37. Singh M., Rosen C.L., Chang K.J., and Haddad G.G. Plasma beta-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. Pediatr Res 26 July (1) (1989) 34-38
38. Sokolov O.Y., Kost N.V., Zolotarev Y.A., Ryukert E.N., and Zozulya A.A. Influence of human β-casomorphin-7 on specific binding of 3H-spiperone to the 5-HT2-receptors of rat brain frontal cortex. Protein Pept Lett 13 2 (2006) 169-170
39. 2-serotonin receptors. Bull Exp Biol Med 140 November (5) (2005) 582-584
40. Svedberg J., de Haas J., Leimenstoll G., Paul F., and Teschemacher H. Demonstration of beta-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 6 September-October (5) (1985) 825-830
41. Teschemacher H., Koch G., and Brantl V. Milk protein-derived opioid receptor ligands. Biopolymers 43 2 (1997) 99-117
42. Thomson A.B., and Keelan M. The development of the small intestine. Can J Physiol Pharmacol 64 January (1) (1986) 13-29
43. Volterra A., Restani P., Brunello N., Galli C.L., and Racagni G. Interaction of β-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain. Dev Brain Res 30 (1986) 25-30
44. Zoghbi S., Trompette A., Claustre J., El Homsi M., Garzón J., Jourdan G., et al. beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway. Am J Physiol Gastrointest Liver Physiol 290 6 (2006) G1105-G1113
45. Zong Y.F., Chen W.H., Zhang Y.S., and Zou S.X. Effects of intra-gastric beta-casomorphin-7 on somatostatin and gastrin gene expression in rat gastric mucosa. World J Gastroenterol 13 14 (2007) 2094-2099